WOUNDTEK, INC ANNOUNCES NEW ADDITION TO ITS BOARD OF DIRECTORS: DAVE JOHNSON OF AMERICAN POWER CONVERSION (NYSE:APCC)

NEWPORT, RI, October 22, 2006 -- WoundTEK, Inc., a privately held medical device company, announced today that it has recruited a new member to its Board of Directors; David Johnson, Vice President of Global Sales and Marketing for American Power Conversion.

"We are very happy to welcome David Johnson to our team of Directors. Dave has a great track record for success. He brings a unique skill set to bear that will help us grow our company rapidly and successfully over the years to come.” Said Andrew Reilly, WoundTEK, Inc. Chief Executive.

WoundTEK, Inc., which grew over 300% in revenues in the first three quarters of 2006 is poised to become a leader in the wound closure market space. “I am delighted to be part of such a strong team and to be involved with a company that looks poised to become a leader in its market place”, said Dave Johnson.

Dave is currently the Vice President of Global Sales and Marketing for American Power Conversion with annual revenues exceeding $2 billion, is the leading provider of hardware and software designed to protect computer, networking, and storage equipment for both business and consumer applications. As Vice President of Global Sales and Marketing he leads APC’s regional and global teams with staff of approximately 2000 people. Dave has also served as Vice President of the Americas leading the sales and marketing of APC solutions in North and Latin America where he was responsible for revenue in excess of $1 billion annually. He also served as general manager, APC Rack Systems, a $200 million product division of APC. Since joining APC in1989, Dave has held multiple product management, sales management and general management positions. Dave began his career with GE Plastics, serving as a financial analyst from1986 to 1989. Johnson has a BS in Economics from Cornell University. He is married with three children and resides in Middletown, RI.

WoundTEK, Inc based in Newport, RI is a medical device company focused on the closure of large wounds and skin deficits caused by trauma or surgery. The company manufactures The S.T.A.R. Device. The first minimally invasive tissue expansion device, The S.T.A.R. rapidly closes large open wounds that cannot be closed using primary closure methods. The S.T.A.R. is a simple, effective and proven method of closing large wounds, chronic wounds, and skin deficits.

Large wound closure is a major health care problem worldwide and is one of the leading causes of deadly infections in the United States. Almost 2,00,000 trauma cases and surgical procedures each year are faced with the challenge of closing large wounds and skin deficits. Current procedures to close large wounds can be technically demanding, increase the risk of infection, and be very invasive, painful, and have deep scaring effects to the tissue. The S.T.A.R. System reduces many of the challenges that are currently faced by surgeons today.

# # #

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including the following: timing and success of product development and market acceptance of developed products; regulatory approvals, clearances and restrictions; guidelines and recommendations in the health care and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which WoundTEK operates; unanticipated manufacturing disruptions, delays in regulatory approvals of new manufacturing facilities or the inability to meet demand for products. Words such as "estimate," "project," "plan," "intend," "expect," "anticipate," "believe" and similar expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.